News from sanofi us A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

( EuronextParis:SAN,NASDAQ-NMS:REGN,NYSE:SNY)

Feb 09, 2016, 08:05 ET
Sanofi logo.

Sanofi Delivered 2015 Business EPS up 8.5% on a Reported Basis and Stable at Constant Exchange Rates Consistent with Guidance

 Sanofi (NYSE: SNY; EURONEXT: SAN) Q4 2015 Change Change (CER) 2015 Change Change (CER) Aggregate Group...

Feb 09, 2016, 02:14 ET

Sanofi - Résultats 2015

Interview de Olivier Brandicourt, Directeur Général Sanofi, un leader mondial et diversifié de la santé, publie ses...

Feb 09, 2016, 02:12 ET

Sanofi - Full Year 2015 Results

Sanofi, a global and diversified healthcare leader, reports annual results for 2015. CEO Olivier Brandicourt comments on results and...

Dec 23, 2015, 08:00 ET

Sanofi Submits New Drug Application for the Once-Daily Fixed-Ratio Combination of Insulin Glargine and Lixisenatide

 Sanofi announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for its...

Dec 11, 2015, 01:00 ET

Sanofi and Regeneron Announce UnitedHealth Group Selects Praluent® (alirocumab) Injection for Preferred Access

 Sanofi and Regeneron Pharmaceuticals, Inc. today announced that UnitedHealth Group will provide preferred access to Praluent®...

Dec 01, 2015, 08:35 ET
Priftin® rifapentine tablets 150mg 24 tablets

Sanofi Launches New Priftin® (Rifapentine) Packaging

 Sanofi announced today the launch of a new 24-count tablet pack of Priftin® (rifapentine) for the treatment of latent tuberculosis...

Nov 20, 2015, 08:35 ET
U.S. Counterfeit Medicines Survey Infographic

Perceptions of Counterfeit Medicines: Only 12% of Americans Feel They Have Enough Information

Sanofi announced today the results of a new study examining perceptions of the risks associated with counterfeit medicines. Conducted in July 2015,...

Nov 10, 2015, 18:01 ET

Sanofi and Regeneron Announce New Praluent® (alirocumab) Injection Analyses Presented at AHA Scientific Sessions 2015

 Sanofi and Regeneron Pharmaceuticals, Inc. today announced a new post-hoc analysis of six Phase 3 clinical trials showing that approximately...

Nov 08, 2015, 07:08 ET

Sanofi and Regeneron Present Results from Pivotal Phase 3 Study of Sarilumab at American College of Rheumatology Annual Meeting

 Sanofi and Regeneron Pharmaceuticals, Inc. today announced results from a pivotal Phase 3 study of sarilumab, an investigational, human...

Nov 06, 2015, 08:00 ET

Sanofi and Lexicon Pharmaceuticals To Collaborate on Sotagliflozin, an Investigational New Oral Medicine for People with Diabetes

Sanofi and Lexicon Pharmaceuticals (NASDAQ: LXRX), Inc. announced today that they have entered into a collaboration and license agreement for the...

Nov 06, 2015, 01:01 ET

Sanofi and Lexicon Pharmaceuticals to Collaborate on Sotagliflozin, an Investigational New Oral Medicine for People with Diabetes

 Sanofi (EURONEXT: SAN and NYSE: SNY) and Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) announced today that they have entered into a...

Nov 05, 2015, 08:00 ET

Sanofi and Regeneron to Present Results from Phase 3 Praluent® (alirocumab) Injection Clinical Trials at AHA Scientific Sessions 2015

What:  Sanofi and Regeneron Pharmaceuticals, Inc. today announced that new data from the Praluent clinical trial program will be...

Nov 05, 2015, 08:00 ET

Sanofi and Hanmi Announce License Agreement To Develop Portfolio of Long-Acting Diabetes Treatments

 Sanofi and Hanmi Pharmaceutical Co., Ltd. announced today a worldwide license agreement to develop a portfolio of experimental, long-acting...

Oct 29, 2015, 17:42 ET
AUVI-Q

Update: Sanofi US Issues Voluntary Nationwide Recall of Auvi-Q® Due to Potential Inaccurate Dosage Delivery

 This post was authored by Dr. Paul Chew, Global Chief Medical Officer, Sanofi and was originally published on the Speaking of Sanofi blog on...

Oct 29, 2015, 08:35 ET
Sanofi logo.

Sanofi Grew Sales and Business EPS in Q3 2015

 Sanofi (NYSE: SNY; EURONEXT: SAN) Q3 2015 Change (reported) Change (CER) Net...

Oct 29, 2015, 03:58 ET

Sanofi - Résultats T3 2015

Interview de Jérôme Contamine, Directeur Financier  Sanofi, un leader mondial et diversifié de la santé, publie ses...

Oct 29, 2015, 03:53 ET

Sanofi - Q3 2015 Results

Sanofi, a global and diversified healthcare leader, reports results for the third quarter of 2015. Jérôme Contamine, Chief Financial...

Oct 28, 2015, 16:16 ET
AUVI-Q

Sanofi US Issues Voluntary Nationwide Recall of Auvi-Q® Due to Potential Inaccurate Dosage Delivery

 Sanofi US is voluntarily recalling all Auvi-Q® (epinephrine injection, USP). The recall involves all Auvi-Q currently on the market...

Oct 20, 2015, 03:00 ET

Un réseau international d'hôpitaux fait le bilan des formes sévères de la grippe saisonnière 2014-2015 lors de sa réunion annuelle

- La grippe peut entraîner un taux important d'hospitalisations à travers le monde -   - La vaccination réduit de façon...

Oct 15, 2015, 11:00 ET

Sanofi Pasteur and the Infectious Disease Research Institute Partner on a Global-Health, Open-Innovation, Vaccine Research & Development Center

Sanofi Pasteur, the vaccines division of Sanofi, announced today the creation of a Global Health Vaccine Center of Innovation (GHVCI) with the...